Correlation Engine 2.0
Clear Search sequence regions


  • cell islets (1)
  • human (4)
  • islet (9)
  • like (6)
  • patients (1)
  • research (3)
  • stem cells (2)
  • Sizes of these terms reflect their relevance to your search.

    The scarcity of human cadaver islets for transplantation in patients with Diabetes Mellitus (DM) has necessitated the search for alternative islet sources. With advancing islet biology research, islet-like clusters (ILCs) derived from stem cells have demonstrated potential for treating DM and in novel drug discovery programs for drug and cytotoxicity testing. In vitro differentiation of ILCs from stem cells also provides an opportunity to mimic the in vivo islet developmental pathways. In vitro derived ILCs are often considered immature,as they do not respond to glucose challenge efficiently. However, the in vitro and in vivo performance of ILCs can be imroved by pharmacological preconditioning. In this review, we discuss how ILCs generated from human postnatal tissues can be utilized as an in-vitro model to study cytotoxicity, drug screening and enhancement of transplantation efficacy. Use of human cadevar islets is not permitted for research purposes in India. Under these restrictions, the application of ILCs in drug screening and their role in complementing, reducing, and replacing animal testing will evolve a reliable platform in vitro screening as well as for stem cell-based treatment in DM. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

    Citation

    Avinash Kharat, Bhawna Chadravanshi, Avinash Sanap, Supriya Kheur, Ramesh Bhonde. Human Postnatal Mesenchymalstem Cell Derived Islets as a Model for Diabetes Research. Current diabetes reviews. 2020 Dec 14


    PMID: 33319675

    View Full Text